Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCERT-HF: Autologous MSCs and c-kit+ Cells in Ischemic Heart Failure
NCT02501811Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Oct 2015
- Primary completion
- Jun 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells, autologous c-kit+ cardiac stem cells in ischemic cardiomyopathy (ICM), sponsored by UTHealth Houston. Started Oct 2015; status: completed.
02
Drugs
mesenchymal stem cellsautologous c-kit+ cardiac stem cells
03
Conditions
ischemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NCT02501811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02501811.